Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Dec;35(12):3098–3103. doi: 10.1128/jcm.35.12.3098-3103.1997

Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis.

M Gabbott 1, Y E Cossart 1, A Kan 1, M Konopka 1, R Chan 1, B R Rose 1
PMCID: PMC230129  PMID: 9399501

Abstract

This study provides the first systematic evaluation of papillomavirus type and viral mutation occurring during the course of juvenile-onset recurrent respiratory papillomatosis. One hundred ninety-nine consecutive papillomas excised from 47 children between 1981 and 1996 at The New Children's Hospital in Sydney, Australia, were tested for human papillomavirus (HPV) DNA by PCR. PCR products from the viral upstream regulatory region (URR) enhancer were sequenced, and variation was related to clinical variables. Forty-four of the 47 children had HPV-induced papillomas, with type 11 accounting for 24 (55%) and type 6 accounting for 19 (43%); one (2%) was positive for either type 6 or 11. Overall, 183 (98%) of the 186 samples with amplifiable DNA were HPV positive. There was no change in HPV type over time and no statistically significant association between HPV type and disease aggressiveness. One novel, large-scale URR duplication was identified in an HPV type 11 isolate in the last of a series of six papillomas examined and the first from the bronchus. However, the duplication was not found in HPV type 11 isolates from the associated pulmonary carcinoma and its metastases in other organs. Three of 14 URR point mutations coincided with transcription factor binding sites, but there were no obvious associations with clinical course. Chi-square and multiple linear regression analyses of clinicopathological variables revealed early age at diagnosis (less than 4 years) as an independent predictor of aggressive disease (P < 0.001). A bimodal distribution of the age at diagnosis was noted, with peaks at 2 and 11 years of age.

Full Text

The Full Text of this article is available as a PDF (383.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonagura V. R., Siegal F. P., Abramson A. L., Santiago-Schwarz F., O'Reilly M. E., Shah K., Drake D., Steinberg B. M. Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin Diagn Lab Immunol. 1994 May;1(3):357–360. doi: 10.1128/cdli.1.3.357-360.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  3. Byrne J. C., Tsao M. S., Fraser R. S., Howley P. M. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med. 1987 Oct 1;317(14):873–878. doi: 10.1056/NEJM198710013171406. [DOI] [PubMed] [Google Scholar]
  4. Corbitt G., Zarod A. P., Arrand J. R., Longson M., Farrington W. T. Human papillomavirus (HPV) genotypes associated with laryngeal papilloma. J Clin Pathol. 1988 Mar;41(3):284–288. doi: 10.1136/jcp.41.3.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Derkay C. S. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg. 1995 Dec;121(12):1386–1391. doi: 10.1001/archotol.1995.01890120044008. [DOI] [PubMed] [Google Scholar]
  6. DiLorenzo T. P., Tamsen A., Abramson A. L., Steinberg B. M. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol. 1992 Feb;73(Pt 2):423–428. doi: 10.1099/0022-1317-73-2-423. [DOI] [PubMed] [Google Scholar]
  7. Dickens P., Srivastava G., Loke S. L., Larkin S. Human papillomavirus 6, 11, and 16 in laryngeal papillomas. J Pathol. 1991 Nov;165(3):243–246. doi: 10.1002/path.1711650308. [DOI] [PubMed] [Google Scholar]
  8. Doyle D. J., Gianoli G. J., Espinola T., Miller R. H. Recurrent respiratory papillomatosis: juvenile versus adult forms. Laryngoscope. 1994 May;104(5 Pt 1):523–527. doi: 10.1002/lary.5541040503. [DOI] [PubMed] [Google Scholar]
  9. Doyle D. J., Henderson L. A., LeJeune F. E., Jr, Miller R. H. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Arch Otolaryngol Head Neck Surg. 1994 Nov;120(11):1273–1276. doi: 10.1001/archotol.1994.01880350079014. [DOI] [PubMed] [Google Scholar]
  10. Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I., Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol. 1991 May;72(Pt 5):1039–1044. doi: 10.1099/0022-1317-72-5-1039. [DOI] [PubMed] [Google Scholar]
  11. Greer C. E., Wheeler C. M., Manos M. M. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl. 1994 Jun;3(6):S113–S122. doi: 10.1101/gr.3.6.s113. [DOI] [PubMed] [Google Scholar]
  12. Guillou L., Sahli R., Chaubert P., Monnier P., Cuttat J. F., Costa J. Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol. 1991 Sep;15(9):891–898. doi: 10.1097/00000478-199109000-00010. [DOI] [PubMed] [Google Scholar]
  13. Hartley C., Hamilton J., Birzgalis A. R., Farrington W. T. Recurrent respiratory papillomatosis--the Manchester experience, 1974-1992. J Laryngol Otol. 1994 Mar;108(3):226–229. [PubMed] [Google Scholar]
  14. Hasan S., Dutt S. N., Kini U., Shariff S., Nalinesha K. M., Prasad D. Laryngeal carcinoma ex-papilloma in a non-irradiated, non-smoking patient: a clinical record and review of the literature. J Laryngol Otol. 1995 Aug;109(8):762–766. doi: 10.1017/s0022215100131251. [DOI] [PubMed] [Google Scholar]
  15. Heinzel P. A., Chan S. Y., Ho L., O'Connor M., Balaram P., Campo M. S., Fujinaga K., Kiviat N., Kuypers J., Pfister H. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol. 1995 Jul;33(7):1746–1754. doi: 10.1128/jcm.33.7.1746-1754.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kashima H. K., Shah K. Recurrent respiratory papillomatosis. Clinical overview and management principles. Obstet Gynecol Clin North Am. 1987 Jun;14(2):581–588. [PubMed] [Google Scholar]
  17. Kitasato H., Delius H., zur Hausen H., Sorger K., Rösl F., de Villiers E. M. Sequence rearrangements in the upstream regulatory region of human papillomavirus type 6: are these involved in malignant transition? J Gen Virol. 1994 May;75(Pt 5):1157–1162. doi: 10.1099/0022-1317-75-5-1157. [DOI] [PubMed] [Google Scholar]
  18. Lindeberg H., Elbrønd O. Laryngeal papillomas: clinical aspects in a series of 231 patients. Clin Otolaryngol Allied Sci. 1989 Aug;14(4):333–342. doi: 10.1111/j.1365-2273.1989.tb00381.x. [DOI] [PubMed] [Google Scholar]
  19. May M., Dong X. P., Beyer-Finkler E., Stubenrauch F., Fuchs P. G., Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 1994 Mar 15;13(6):1460–1466. doi: 10.1002/j.1460-2075.1994.tb06400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McGlennen R. C., Ghai J., Ostrow R. S., LaBresh K., Schneider J. F., Faras A. J. Cellular transformation by a unique isolate of human papillomavirus type 11. Cancer Res. 1992 Nov 1;52(21):5872–5878. [PubMed] [Google Scholar]
  21. Mounts P., Shah K. V., Kashima H. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5425–5429. doi: 10.1073/pnas.79.17.5425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Padayachee A., Prescott C. A. Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The Red Cross War Memorial Children's Hospital experience 1982-1988. Int J Pediatr Otorhinolaryngol. 1993 Mar;26(2):141–147. doi: 10.1016/0165-5876(93)90019-y. [DOI] [PubMed] [Google Scholar]
  23. Pou A. M., Rimell F. L., Jordan J. A., Shoemaker D. L., Johnson J. T., Barua P., Post J. C., Ehrlich G. D. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol. 1995 Oct;104(10 Pt 1):758–762. doi: 10.1177/000348949510401002. [DOI] [PubMed] [Google Scholar]
  24. Resnick R. M., Cornelissen M. T., Wright D. K., Eichinger G. H., Fox H. S., ter Schegget J., Manos M. M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990 Sep 19;82(18):1477–1484. doi: 10.1093/jnci/82.18.1477. [DOI] [PubMed] [Google Scholar]
  25. Rose B. R., Thompson C. H., Zhang J., Stoeter M., Stephen A., Pfister H., Tattersall M. H., Cossart Y. E. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol. 1997 Aug;66(2):282–289. doi: 10.1006/gyno.1997.4740. [DOI] [PubMed] [Google Scholar]
  26. Shibata D. K., Arnheim N., Martin W. J. Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med. 1988 Jan 1;167(1):225–230. doi: 10.1084/jem.167.1.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Smith E. M., Pignatari S. S., Gray S. D., Haugen T. H., Turek L. P. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg. 1993 May;119(5):554–557. doi: 10.1001/archotol.1993.01880170080017. [DOI] [PubMed] [Google Scholar]
  28. Strong M. S., Vaughan C. W., Cooperband S. R., Healy G. B., Clemente M. A. Recurrent respiratory papillomatosis: management with the CO2 laser. Ann Otol Rhinol Laryngol. 1976 Jul-Aug;85(4 Pt 1):508–516. doi: 10.1177/000348947608500412. [DOI] [PubMed] [Google Scholar]
  29. Tieben L. M., ter Schegget J., Minnaar R. P., Bouwes Bavinck J. N., Berkhout R. J., Vermeer B. J., Jebbink M. F., Smits H. L. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods. 1993 May;42(2-3):265–279. doi: 10.1016/0166-0934(93)90038-s. [DOI] [PubMed] [Google Scholar]
  30. de Roda Husman A. M., Walboomers J. M., van den Brule A. J., Meijer C. J., Snijders P. J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995 Apr;76(Pt 4):1057–1062. doi: 10.1099/0022-1317-76-4-1057. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES